Direct Access to our Principal Scientists

With three Principal Scientists on staff, and our founder who co-pioneered Single-Step cloning and our B-cell Select platform, we offer professional consultation and consulting services for your R&D needs.

A Personalized Approach to Your Most Difficult Projects

Project personalization starts with a dedicated Principal or Senior Scientist as your project lead; to help manage your project today as well as all of your future pipeline custom mAb development needs. Taking this approach enables us to rapidly build a constructive professional working relationship based upon project data driven communications and collaboration. Our belief in actively investing in our client relationships has greatly aided us and our clients grow over the past 25 years through successful, high quality project outcomes.

Proprietary Technologies to Rapidly Provide High Affinity mAbs

IPA uses proprietary and innovative inoculation and cloning technologies, as well as established expertise, to produce mAbs significantly faster than traditional methods of antibody production. With these capacities IPA has produced hundreds of mAbs, many of which are now being sold commercially through industry partners.

Adaptive Lab Operations Allowing for In Process Project Add-Ons

To service your most difficult projects, our lab operations have been structured around providing project flexibility with the ability for in-process project add-ons. Additionally, we have established specific client touchpoints to review preliminary project results and discuss any changes to project direction to help clients get the most out of their investment.

See our add-ons:

  • In vitro bioreactor concentration
  • In vivo ascites production
  • Small and large scale antibody purification
  • Specialized assays
  • Media choice options
  • Cell banking and cryostorage

Key Milestones Achieved